您当前位置：首页 > 国际期刊-ANTI-CANCER DRUGS期刊投稿发表详细信息

ANTI-CANCER DRUGS Q3

期刊收录：
SCIE
Scopus

基本信息

期刊ISSN：
0959-4973
期刊简拼：
ANTI-CANCER DRUG
年发文章数：
142
E-ISSN：
1473-5741
Gold OA文章占比
18.89%
研究文章占比：
86.62%
是否OA：
No
Jcr分区：
Q3
中科院分区：
4区

出版信息

出版商：
Lippincott Williams and Wilkins Ltd.
涉及研究方向：
医学-药学
出版国家：
UNITED STATES
出版语言：
English
出版周期：
Monthly
出版年份：
1990

2023-2024最新影响因子:1.8
自引率:0.00%
五年影响因子:1.9
JCI期刊引文指标:0.63
h-index:88
CiteScore:3.80

期刊关键词

3区 SCIE Scopus 医学 4区 ONCOLOGY 肿瘤学 PHARMACOLOGY & PHARMACY 药学

期刊简介

Anti-Cancer Drugs reports both clinical and experimental results related to anti-cancer drugs, and welcomes contributions on anti-cancer drug design, drug delivery, pharmacology, hormonal and biological modalities and chemotherapy evaluation. An internationally refereed journal devoted to the fast publication of innovative investigations on therapeutic agents against cancer, Anti-Cancer Drugs aims to stimulate and report research on both toxic and non-toxic anti-cancer agents. Consequently, the scope on the journal will cover both conventional cytotoxic chemotherapy and hormonal or biological response modalities such as interleukins and immunotherapy. Submitted articles undergo a preliminary review by the editor. Some articles may be returned to authors without further consideration. Those being considered for publication will undergo further assessment and peer-review by the editors and those invited to do so from a reviewer pool.

《ANTI-CANCER DRUGS》期刊已被查看：次
期刊简写：ANTI-CANCER DRUG

此期刊被最新的JCR期刊SCIE收录